Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 226Active not recruiting 206Completed 113Not yet recruiting 40Terminated 34Withdrawn 3Suspended 2Enrolling by invitation 2No longer available 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Muscle Invasive Bladder Urothelial Carcinoma 1Clinical Stage I Gastric Cancer AJCC v8 1

Interventions

Educational Status 7Standard of Care 5Interviews as Topic 5Cisplatin 5Blood Specimen Collection 5Oxaliplatin 4Surveys and Questionnaires 3Surgical Procedures, Operative 3Specimen Handling 3Patient Navigation 3Observation 3Nivolumab 3Methods 3Magnetic Resonance Imaging 3Fluorouracil 3Early Intervention, Educational 3Biopsy 3toripalimab 2sacituzumab govitecan 2pembrolizumab 2lenvatinib 2Transcutaneous Electric Nerve Stimulation 2Radiosurgery 2Practice Guidelines as Topic 2Platinum Compounds 2Paclitaxel 2Music Therapy 2Magnetic Resonance Spectroscopy 2Leucovorin 2Letrozole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Paclitaxel × 1 year × Clear all
NCT06204614 2026-05-18

Drug Screening Using IMD in Bladder Cancer

Brigham and Women's Hospital

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Muscle Invasive Bladder Urothelial Carcinoma

NCT07139951 2025-12-31

HORIZON

Mayo Clinic

Phase 2 Enrolling by invitation
16 enrolled
Gastrointestinal

Clinical Stage I Gastric Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡